Company A1M Pharma AB Nasdaq Stockholm
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- SEK | - |
|
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 30/11/18 | |
Karin Botha
DFI | Director of Finance/CFO | 51 | 13/09/20 |
Michael Reusch
CTO | Chief Tech/Sci/R&D Officer | 64 | 31/12/21 |
Sara Thuresson
CTO | Chief Tech/Sci/R&D Officer | 48 | 23/05/21 |
Torbjörn Larsson
PRN | Corporate Officer/Principal | - | 30/04/22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Johan Bygge
CHM | Chairman | 68 | 30/04/21 |
Göran Forsberg
BRD | Director/Board Member | 61 | 28/05/19 |
Fredrik Lehmann
BRD | Director/Board Member | 48 | 30/11/22 |
Lars Höckenström
BRD | Director/Board Member | 68 | 22/10/19 |
Johannes Hulthe
BRD | Director/Board Member | 54 | 28/05/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 10,061,615 | 7,464,712 ( 74.19 %) | 0 | 74.19 % |
Company contact information
Guard Therapeutics International AB
Nybrogatan 34 2nd Floor
114 39, Stockholm
+46 86 70 65 51
http://www.guardtherapeutics.com![address A1M Pharma AB](https://cdn.zonebourse.com/static/address/34972723.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+38.65% | 39.1B | |
-8.62% | 38.76B | |
+26.95% | 31.24B | |
+10.74% | 25.9B | |
-13.50% | 25.8B | |
+44.87% | 14.06B | |
+34.36% | 13.12B | |
-7.14% | 11.32B | |
-12.61% | 10.68B |
- Stock Market
- Equities
- GUARD Stock
- Stock
- Company A1M Pharma AB